NM_000135.4:c.1049G>A
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_000135.4(FANCA):c.1049G>A(p.Arg350Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,613,430 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R350W) has been classified as Likely benign.
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000135.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | NM_000135.4 | MANE Select | c.1049G>A | p.Arg350Gln | missense | Exon 12 of 43 | NP_000126.2 | ||
| FANCA | NM_001286167.3 | c.1049G>A | p.Arg350Gln | missense | Exon 12 of 43 | NP_001273096.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | TSL:1 MANE Select | c.1049G>A | p.Arg350Gln | missense | Exon 12 of 43 | ENSP00000373952.3 | ||
| FANCA | ENST00000567205.2 | TSL:1 | n.1049G>A | non_coding_transcript_exon | Exon 12 of 27 | ENSP00000457027.2 | |||
| FANCA | ENST00000564475.6 | TSL:2 | c.1049G>A | p.Arg350Gln | missense | Exon 12 of 42 | ENSP00000454977.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000133 AC: 33AN: 249016 AF XY: 0.000126 show subpopulations
GnomAD4 exome AF: 0.000170 AC: 248AN: 1461158Hom.: 2 Cov.: 32 AF XY: 0.000154 AC XY: 112AN XY: 726874 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74468 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:2Benign:1
Fanconi anemia complementation group A Uncertain:2
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
not provided Uncertain:1
DNA sequence analysis of the FANCA gene demonstrated a sequence change, c.1049G>A, in exon 12 that results in an amino acid change, p.Arg350Gln. This sequence change does not appear to have been previously described in individuals with FANCA-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.15% in the East Asian subpopulation (dbSNP rs199967286). The p.Arg350Gln change affects a moderately conserved amino acid residue located in a domain of the FANCA protein that is not known to be functional. The p.Arg350Gln substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Arg350Gln change remains unknown at this time.
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at